Galderma Group AG (GALDY)
OTCMKTS · Delayed Price · Currency is USD
38.31
-2.21 (-5.45%)
Mar 10, 2026, 2:44 PM EST
Galderma Group AG Revenue
In the year 2025, Galderma Group AG had annual revenue of $5.24B with 18.04% growth. Galderma Group AG had revenue of $2.78B in the half year ending December 31, 2025, with 32.02% growth.
Revenue
5.24B
Revenue Growth
+18.04%
P/S Ratio
8.91
Revenue / Employee
682.78K
Employees
7,676
Market Cap
46.72B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 5.24B | 801.00M | 18.04% |
| Dec 31, 2024 | 4.44B | 323.00M | 7.85% |
| Dec 31, 2023 | 4.12B | 293.10M | 7.66% |
| Dec 31, 2022 | 3.82B | 378.90M | 11.00% |
| Dec 31, 2021 | 3.45B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sofgen Pharma | 423.75M |
| Jushi Holdings | 260.43M |
| Glass House Brands | 196.17M |
| MariMed | 157.38M |
| Elite Pharmaceuticals | 140.12M |
| Earth Science Tech | 34.87M |
| Radnostix | 14.07M |
| Healthy Extracts | 3.59M |